TTNP logo

Titan Pharmaceuticals (TTNP) Total Liabilities

Annual Total Liabilities

$1.44 M
-$1.25 M-46.42%

December 31, 2023


Summary


Performance

TTNP Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTTNPbalance sheetmetrics:

Quarterly Total Liabilities

$371.00 K
+$15.00 K+4.21%

September 30, 2024


Summary


Performance

TTNP Quarterly Total Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTTNPbalance sheetmetrics:

Total Liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

TTNP Total Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-46.4%-74.3%
3 y3 years-68.3%-84.8%
5 y5 years-80.1%-90.3%

TTNP Total Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-49.4%at low-87.0%+4.2%
5 y5-year-82.2%at low-95.8%+4.2%
alltimeall time-97.0%at low-99.2%+4.2%

Titan Pharmaceuticals Total Liabilities History

DateAnnualQuarterly
Sep 2024
-
$371.00 K(+4.2%)
Jun 2024
-
$356.00 K(-36.3%)
Mar 2024
-
$559.00 K(-61.3%)
Dec 2023
$1.44 M(-46.4%)
$1.44 M(-22.6%)
Sep 2023
-
$1.87 M(+1.1%)
Jun 2023
-
$1.85 M(-25.6%)
Mar 2023
-
$2.48 M(-8.0%)
Dec 2022
$2.69 M(-5.6%)
$2.69 M(-1.1%)
Sep 2022
-
$2.73 M(+2.8%)
Jun 2022
-
$2.65 M(+8.9%)
Mar 2022
-
$2.44 M(-14.7%)
Dec 2021
$2.86 M(-37.3%)
$2.86 M(+33.4%)
Sep 2021
-
$2.14 M(-22.4%)
Jun 2021
-
$2.76 M(-28.2%)
Mar 2021
-
$3.84 M(-15.6%)
Dec 2020
$4.55 M(-43.7%)
$4.55 M(-48.9%)
Sep 2020
-
$8.91 M(+8.7%)
Jun 2020
-
$8.20 M(+2.7%)
Mar 2020
-
$7.99 M(-1.3%)
Dec 2019
$8.09 M(+11.4%)
$8.09 M(+1.6%)
Sep 2019
-
$7.96 M(+8.6%)
Jun 2019
-
$7.33 M(-12.6%)
Mar 2019
-
$8.38 M(+15.4%)
Dec 2018
$7.26 M(-9.7%)
$7.26 M(+14.1%)
Sep 2018
-
$6.37 M(+7.3%)
Jun 2018
-
$5.93 M(-3.4%)
Mar 2018
-
$6.14 M(-23.8%)
Dec 2017
$8.05 M(+47.0%)
$8.05 M(-7.5%)
Sep 2017
-
$8.70 M(+363.9%)
Jun 2017
-
$1.88 M(-24.0%)
Mar 2017
-
$2.47 M(-54.9%)
Dec 2016
$5.48 M(-13.0%)
$5.48 M(-33.8%)
Sep 2016
-
$8.27 M(+8.6%)
Jun 2016
-
$7.62 M(+16.8%)
Mar 2016
-
$6.52 M(+3.5%)
Dec 2015
$6.30 M(-48.6%)
$6.30 M(+5.1%)
Sep 2015
-
$5.99 M(-60.9%)
Jun 2015
-
$15.33 M(+8.0%)
Mar 2015
-
$14.20 M(+16.0%)
Dec 2014
$12.24 M(-3.3%)
$12.24 M(+36.5%)
Sep 2014
-
$8.96 M(-16.9%)
Jun 2014
-
$10.79 M(-8.9%)
Mar 2014
-
$11.84 M(-6.5%)
Dec 2013
$12.66 M(-73.6%)
$12.66 M(-12.7%)
Sep 2013
-
$14.50 M(-1.8%)
Jun 2013
-
$14.76 M(-44.5%)
Mar 2013
-
$26.58 M(-44.6%)
Dec 2012
$47.95 M(+58.3%)
$47.95 M(+26.6%)
Sep 2012
-
$37.88 M(+14.6%)
Jun 2012
-
$33.05 M(+5.9%)
Mar 2012
-
$31.20 M(+3.0%)
Dec 2011
$30.30 M(+180.4%)
$30.30 M(+25.7%)
Sep 2011
-
$24.10 M(-6.7%)
Jun 2011
-
$25.83 M(+89.3%)
Mar 2011
-
$13.64 M(+26.3%)
Dec 2010
$10.80 M
$10.80 M(+1.0%)
DateAnnualQuarterly
Sep 2010
-
$10.70 M(+152.8%)
Jun 2010
-
$4.23 M(-45.9%)
Mar 2010
-
$7.83 M(+99.0%)
Dec 2009
$3.93 M(-7.6%)
$3.93 M(-13.7%)
Sep 2008
-
$4.55 M(-9.7%)
Jun 2008
-
$5.04 M(+14.6%)
Mar 2008
-
$4.40 M(+3.4%)
Dec 2007
$4.26 M(+25.4%)
$4.26 M(+47.6%)
Sep 2007
-
$2.88 M(-11.2%)
Jun 2007
-
$3.25 M(-1.7%)
Mar 2007
-
$3.30 M(-2.7%)
Dec 2006
$3.39 M(+8.2%)
$3.39 M(-18.0%)
Sep 2006
-
$4.14 M(+38.0%)
Jun 2006
-
$3.00 M(-6.7%)
Mar 2006
-
$3.21 M(+2.5%)
Dec 2005
$3.14 M(-14.6%)
$3.14 M(-30.1%)
Sep 2005
-
$4.49 M(+30.9%)
Jun 2005
-
$3.43 M(-23.2%)
Mar 2005
-
$4.47 M(+21.7%)
Dec 2004
$3.67 M(+9.9%)
$3.67 M(+10.5%)
Sep 2004
-
$3.32 M(+26.2%)
Jun 2004
-
$2.63 M(-36.9%)
Mar 2004
-
$4.17 M(+24.9%)
Dec 2003
$3.34 M(-15.3%)
$3.34 M(-11.7%)
Sep 2003
-
$3.79 M(-5.2%)
Jun 2003
-
$3.99 M(+1.4%)
Mar 2003
-
$3.94 M(-0.3%)
Dec 2002
$3.94 M(-31.6%)
$3.94 M(+15.4%)
Sep 2002
-
$3.42 M(-9.1%)
Jun 2002
-
$3.76 M(+8.2%)
Mar 2002
-
$3.47 M(-39.7%)
Dec 2001
$5.76 M(+134.0%)
$5.76 M(+128.7%)
Sep 2001
-
$2.52 M(-13.5%)
Jun 2001
-
$2.91 M(+11.2%)
Mar 2001
-
$2.62 M(+6.4%)
Dec 2000
$2.46 M(+29.6%)
$2.46 M(-17.2%)
Sep 2000
-
$2.98 M(+88.4%)
Jun 2000
-
$1.58 M(-28.2%)
Mar 2000
-
$2.20 M(+15.7%)
Dec 1999
$1.90 M(+18.8%)
$1.90 M(+58.3%)
Sep 1999
-
$1.20 M(-29.4%)
Jun 1999
-
$1.70 M(+6.3%)
Mar 1999
-
$1.60 M(0.0%)
Dec 1998
$1.60 M(-77.8%)
$1.60 M(+33.3%)
Sep 1998
-
$1.20 M(0.0%)
Jun 1998
-
$1.20 M(-14.3%)
Mar 1998
-
$1.40 M(-80.6%)
Dec 1997
$7.20 M(+89.5%)
$7.20 M(-8.9%)
Sep 1997
-
$7.90 M(-21.0%)
Jun 1997
-
$10.00 M(-9.9%)
Mar 1997
-
$11.10 M(+192.1%)
Dec 1996
$3.80 M(-59.1%)
$3.80 M(+11.8%)
Sep 1996
-
$3.40 M(-5.6%)
Jun 1996
-
$3.60 M(-14.3%)
Mar 1996
-
$4.20 M(-54.8%)
Dec 1995
$9.30 M
$9.30 M

FAQ

  • What is Titan Pharmaceuticals annual total liabilities?
  • What is the all time high annual total liabilities for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals annual total liabilities year-on-year change?
  • What is Titan Pharmaceuticals quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals quarterly total liabilities year-on-year change?

What is Titan Pharmaceuticals annual total liabilities?

The current annual total liabilities of TTNP is $1.44 M

What is the all time high annual total liabilities for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high annual total liabilities is $47.95 M

What is Titan Pharmaceuticals annual total liabilities year-on-year change?

Over the past year, TTNP annual total liabilities has changed by -$1.25 M (-46.42%)

What is Titan Pharmaceuticals quarterly total liabilities?

The current quarterly total liabilities of TTNP is $371.00 K

What is the all time high quarterly total liabilities for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high quarterly total liabilities is $47.95 M

What is Titan Pharmaceuticals quarterly total liabilities year-on-year change?

Over the past year, TTNP quarterly total liabilities has changed by -$1.07 M (-74.31%)